Development of DNA Methyltransferase Inhibitors for the Treatment of Neoplastic Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|16|17|2075-2085

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.17, 2009-06, pp. : 2075-2085

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Utility of DNA Methyltransferase Inhibitors for the Treatment of Myelodysplastic Syndromes

By  

Current Pharmaceutical Design, Vol. 18, Iss. 22, 2012-07 ,pp. : 3190-3197

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix Metalloproteinase Inhibitors as Prospective Agents for the Prevention and Treatment of Cardiovascular and Neoplastic Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-02 ,pp. : 289-316

Bentham Science Publishers

Access to resources Recommend Favorite

Six (or More) Drugs in Search of a Mechanism: DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes

By Gore Steven D.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 1, 2006-01 ,pp. : 83-90

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Epigenetic cancer therapies: DNA methyltransferase inhibitors

By Brown Robert   Strathdee Gordon  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 747-754

Informa Healthcare

Access to resources Recommend Favorite

Molecular Modeling and Virtual Screening of DNA Methyltransferase Inhibitors

By  

Current Pharmaceutical Design, Vol. 19, Iss. 12, 2013-04 ,pp. : 2138-2147

Bentham Science Publishers

Access to resources Recommend Favorite